transform="translate(188.000000, 15.000000)"

P.D. Soros Fellowship for New Americans

Share 0

Rajesh Gupta, 2005

Senior Fellow, Center for Innovation in Global health

Rajesh Gupta is the child of immigrants from India

Fellowship awarded to support work towards an MD in Medicine at Stanford University

Rajesh Gupta, MD, MS, MPH, is Head of the Global Health Portfolio at Vir Biotechnology and is also a member of Vir's COVID-19 development team. At Vir, he has oversight over therapeutic and vaccine development programs in HIV, TB, malaria, Zika, and other infectious diseases. At Stanford University, he is a Senior Fellow with the Center for Innovation in Global Health. 

Rajesh was born in New York City to parents who emigrated from India. They are now naturalized citizens and live in Acworth, Georgia.

Rajesh received his MD and MS from Stanford University, his MPH from Yale University, and his BS and BA from Tulane University. 

Rajesh's work in infectious diseases is at the interface of product development, clinical research and program design/implementation. Rajesh has led small and large cross-functional teams in startup environments and Fortune 500 companies and established non-profits, and, most recently, he helped lead the clinical development, approval and market access strategy for one of the first two approved drugs in the last 40 years for multi drug-resistant tuberculosis. Rajesh has held faculty positions at Stanford Medical School and Harvard Medical School, and has authored over 50 publications.


Education
  • MS Health Services Research | Stanford University 2010
  • MD Medicine | Stanford University 2010
  • MPH Public Health | Yale University 1999
  • BA Psychology | Tulane University 1997
  • BS Cellular Biology | Tulane University 1997
Work History
  • Center for Innovation in Global health, Senior Fellow | January 2015 - PRESENT
  • US Centers for Disease Control and Prevention, | January 1997 - December 1998
  • Google.org, | January 2008 - December 2009
  • VIR Biotechnology, Head of Global Health Portfolio | January 2018 - PRESENT
  • Otsuka Pharmaceutical Companies, Senior Director | January 2012 - January 2018
Related Articles
04.03.20

COVID-19: Paul & Daisy Soros Fellows Using Entrepreneurship, Law, and Research to Support the Fight

Paul & Daisy Soros Fellows are using their skills in all fields to support efforts in the COVID crisis in the United States.

Read More